Lifeboat Foundation

In this video, Elon Musk demonstrates a prototype brain–computer interface chip – implanted in a pig – that his company, Neuralink, has been working on. The device could one day be used by humans to augment their abilities.

Founded in 2016, the Neuralink Corporation remained highly secretive about its work until July 2019, when Musk presented his concept at the California Academy of Sciences. It emerged that he planned to create brain–machine interfaces (BMIs) not only for diseased or injured patients, but also healthy individuals who might wish to enhance themselves.

Yesterday, in a livestream event on YouTube, Musk unveiled a pig called Gertrude with a coin-sized chip in her brain. Simpler and smaller than the original revealed last year, the read/write link device can nevertheless pack 1,024 channels with megabit wireless data rate and all-day battery life. This latest prototype – version 0.9 – has now been approved as an FDA breakthrough device, allowing it to be used in limited human trials under the US federal guidelines for testing medical devices. The chip is removable, Musk explained, as he showed another pig called Dorothy, who no longer had the implant and was healthy, happy and indistinguishable from a normal pig.

Summary: Neuroimaging predicts whether a person with OCD will respond to stress-reduction therapy or exposure-based therapy best. Analyzing brain activity may help to provide tailored treatments to individuals suffering from OCD.

Source: Michigan Medicine

New research could improve the odds that people with obsessive-compulsive disorder will receive a therapy that really works for them – something that eludes more than a third of those who currently get OCD treatment.

https://youtube.com/watch?v=OyVGiJacQqI

The tactic has become widespread on battlefields overseas and now appears to be proliferating to organized crime.

Sixty feet beneath the surface of the Caribbean Sea, aquanaut Fabien Cousteau and industrial designer Yves Béhar are envisioning the world’s largest underwater research station and habitat.

The pair have unveiled Fabien Cousteau’s Proteus, a 4,000-square-foot modular lab that will sit under the water off the coast of Curaçao, providing a home to scientists and researchers from across the world studying the ocean — from the effects of climate change and new marine life to medicinal breakthroughs.

Designed as a two-story circular structure grounded to the ocean floor on stilts, Proteus’ protruding pods contain laboratories, personal quarters, medical bays and a moon pool where divers can access the ocean floor. Powered by wind and solar energy, and ocean thermal energy conversion, the structure will also feature the first underwater greenhouse for growing food, as well as a video production facility.

A worldwide pandemic, something that has not occurred for over 100 years is, without question, the story of the year. The impact and ripple effect may take years before analysts are comfortable with knowing what exactly happened. In an amazing effort to curb Covid-19 and keep world economics intact, the United States and foreign countries took extraordinary measures, most of which where thought of, designed, and implemented in days or weeks. There will be plenty of critics.

If the world emerges from this pandemic in the next 6 to 18 months, it will be because of a rapid response. Inflation could be an issue, yet monetary policy enacted was necessary to keep the world from falling into a depression. The issues that won’t be talked about are ones that never happened, thanks to aggressive government action.

In the commodity world, much like the equities, great uncertainty leads to wild volatility. Energy prices dropping into negative territory and milk prices dropping sharply only to rally to all-time new highs illustrate the dichotomy of just how demand (or perception thereof) ebbs and flows at unprecedented speeds. These are just two examples of many markets that experienced extreme price moves.

Summary: A newly designed synthetic compound could act as a prototype for a novel class of drugs to treat neurological damage.

Source: DZNE

Researchers from the German Center for Neurodegenerative Diseases (DZNE), UK and Japan have developed a neurologically acting protein and tested it in laboratory studies. In mice, the experimental compound ameliorated symptoms of certain neurological injuries and diseases, while on the microscopic level it was able to establish and repair connections between neurons. This proof-of-principle study suggests that biologics, which act on neuronal connectivity, could be of clinical use in the long term. The results are published in the journal Science.

A trial by scientists at the University of Alberta is being proposed for an antiviral drug, a protease inhibitor, that was first developed to treat feline coronavirus. The drug has been found to prevent viral replication in human cells infected with SARS-CoV-2.

Antiviral used to treat cat coronavirus also works against SARS-CoV-2.

In this Review, Suhre, McCarthy and Schwenk describe how combining genetics with plasma proteomics is providing notable insights into human disease. As changes in the circulating proteome are often an intermediate molecular readout between a genetic variant and its organismal effect, proteomics can enable a deeper understanding of disease mechanisms, clinical biomarkers and therapeutic opportunities.

Both shocking and intriguing for the possibilities of gynogenesis reproduction in which sperm is used from one creature to fertilize an egg, but its DNA is ignored.

A team of researchers working at Hungary’s National Agricultural Research and Innovation Centre, Research Institute for Fisheries and Aquaculture, has accidentally bred a new kind of fish—dubbed the sturddlefish by some observers, it is a cross between an American Paddlefish and a Russian Sturgeon. In their paper published in the journal Genes, the group describes accidentally breeding the fish and what they learned by doing so.

In the past, scientists and others have bred animals from different species for various reasons, from research to utility—mules (crossed between donkeys and horses) are considered to have beneficial traits from both animals, and ligers (a cross between lions and tigers) have helped researchers understand their respective genetic backgrounds. In this new effort, the researchers claim that they were not trying to create a new type of fish, they were instead attempting to apply gynogenesis (a type of reproduction in which sperm is used from one creature to fertilize an egg, but its DNA is ignored) using American paddlefish and Russian sturgeon. To their surprise, the eggs produced fish that grew to adults.

Continue reading “Researchers accidentally breed sturddlefish” »